Neutra to commence clinical trials of pure plus weight loss formula
Neutra is recruiting volunteers to test the effectiveness of its new, enriched formula and is expected to start the trials shortly. The trials aim at distinguishing Pure Plus
Kyowa Kirin subsidiary Kyowa Kirin EMEA has received approval from the European Commission (EC) to expand the use of Crysvita (burosumab) for treating X-linked hypophosphataemia (XLH) in infants aged one month to one year across the EU and European Economic Area.